Skip to main content
Clinical Trials/NCT04457362
NCT04457362CompletedNot Applicable

A Comparative Study Evaluating the Diagnostic Accuracy of Wrist Arthroscopy Using the NanoScope Compared to Conventional Arthroscopic Instrumentation

NYU Langone Health1 site in 1 country20 target enrollmentStarted: October 10, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope

Study Overview

Brief Summary

The purpose of this study is to evaluate the diagnostic efficacy of Arthrex NanoScope compared to conventional arthroscopic instruments. Patients with wrist pathology who are indicated for an arthroscopic procedure will be enrolled pre-operatively after a thorough discussion of the study aims, risks, and benefits. At the time of surgery, under standard conditions, using standard wrist arthroscopy portals, a diagnostic arthroscopy will be performed with the Arthrex Nanoscope. The diagnostic arthroscopy will be performed in a stepwise manner for consistency with notation of pathology and intended intervention. The diagnostic arthroscopy will then be performed with the standard arthroscopic equipment, again noting pathology and final intervention. Post-operatively, diagnostic accuracy, incidence of change in intervention, and surgeon rated ease of use and confidence will be determined.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > 18 years.
  • Wrist pathology based on clinical examination/imaging studies undergoing wrist arthroscopy for further evaluation/treatment.
  • Willingness to participate in the study

Exclusion Criteria

  • Age < 18 years.

Outcomes

Primary Outcomes

Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope

Time Frame: Day 1

Radiocarpal visualization rated on a 5-point scale: (1) - bad; (2) - poor; (3) - fair; (4) - good; (5) - excellent.

Surgeon-Rated Radiocarpal Visualization With Conventional Instrument

Time Frame: Day 1

Radiocarpal visualization rated on a 5-point scale: (1) - bad; (2) - poor; (3) - fair; (4) - good; (5) - excellent.

Surgeon-Rated Midcarpal Visualization With Arthrex Nanoscope

Time Frame: Day 1

Midcarpal visualization rated on a 5-point scale: (1) - bad; (2) - poor; (3) - fair; (4) - good; (5) - excellent.

Surgeon-Rated Midcarpal Visualization With Conventional Instrument

Time Frame: Day 1

Midcarpal visualization rated on a 5-point scale: (1) - bad; (2) - poor; (3) - fair; (4) - good; (5) - excellent.

Secondary Outcomes

  • Surgeon-rated Ease of Use of Arthrex NanoScope(Day 1)
  • Surgeon-rated Ease of Use of Conventional Instrument(Day 1)
  • Surgeon-rated Confidence in Arthrex NanoScope Diagnosis(Day 1)
  • Surgeon-rated Confidence in Conventional Instrument Diagnosis(Day 1)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Wrist Arthroscopy Study | Clinical Trial